Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 11.4466 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.515 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 11.4165 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.5424 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.0363 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.6973 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.69 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.8589 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 12.0325 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 11.6865 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.4826 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 12.2422 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.6109 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 11.3173 | 99 |